vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and ENTEGRIS INC (ENTG). Click either name above to swap in a different company.
ENTEGRIS INC is the larger business by last-quarter revenue ($823.9M vs $821.5M, roughly 1.0× Acadia Healthcare Company, Inc.). ENTEGRIS INC runs the higher net margin — 6.0% vs -143.3%, a 149.3% gap on every dollar of revenue. On growth, Acadia Healthcare Company, Inc. posted the faster year-over-year revenue change (6.1% vs -3.1%). ENTEGRIS INC produced more free cash flow last quarter ($134.0M vs $-179.5M). Over the past eight quarters, Acadia Healthcare Company, Inc.'s revenue compounded faster (3.4% CAGR vs 3.4%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
Entegris, Inc. is a supplier of materials for the semiconductor and other high-tech industries. Entegris has approximately 8,000 employees throughout its global operations. It has manufacturing, customer service and/or research facilities in the United States, Canada, China, Germany, Israel, Japan, Malaysia, Singapore, South Korea, and Taiwan. The company’s corporate headquarters are in Billerica, Massachusetts.
ACHC vs ENTG — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $821.5M | $823.9M |
| Net Profit | $-1.2B | $49.4M |
| Gross Margin | — | 43.8% |
| Operating Margin | -142.4% | 12.7% |
| Net Margin | -143.3% | 6.0% |
| Revenue YoY | 6.1% | -3.1% |
| Net Profit YoY | -3710.4% | -51.7% |
| EPS (diluted) | $-12.98 | $0.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $821.5M | $823.9M | ||
| Q3 25 | $851.6M | $807.1M | ||
| Q2 25 | $869.2M | $792.4M | ||
| Q1 25 | $770.5M | $773.2M | ||
| Q4 24 | $774.2M | $849.8M | ||
| Q3 24 | $815.6M | $807.7M | ||
| Q2 24 | $796.0M | $812.7M | ||
| Q1 24 | $768.1M | $771.0M |
| Q4 25 | $-1.2B | $49.4M | ||
| Q3 25 | $36.2M | $70.5M | ||
| Q2 25 | $30.1M | $52.8M | ||
| Q1 25 | $8.4M | $62.9M | ||
| Q4 24 | $32.6M | $102.2M | ||
| Q3 24 | $68.1M | $77.6M | ||
| Q2 24 | $78.5M | $67.7M | ||
| Q1 24 | $76.4M | $45.3M |
| Q4 25 | — | 43.8% | ||
| Q3 25 | — | 43.5% | ||
| Q2 25 | — | 44.4% | ||
| Q1 25 | — | 46.1% | ||
| Q4 24 | — | 45.6% | ||
| Q3 24 | — | 46.0% | ||
| Q2 24 | — | 46.2% | ||
| Q1 24 | — | 45.6% |
| Q4 25 | -142.4% | 12.7% | ||
| Q3 25 | 4.7% | 15.2% | ||
| Q2 25 | 5.8% | 13.4% | ||
| Q1 25 | 1.7% | 15.8% | ||
| Q4 24 | 4.9% | 17.6% | ||
| Q3 24 | 12.1% | 16.9% | ||
| Q2 24 | 13.4% | 16.0% | ||
| Q1 24 | 12.9% | 15.3% |
| Q4 25 | -143.3% | 6.0% | ||
| Q3 25 | 4.3% | 8.7% | ||
| Q2 25 | 3.5% | 6.7% | ||
| Q1 25 | 1.1% | 8.1% | ||
| Q4 24 | 4.2% | 12.0% | ||
| Q3 24 | 8.4% | 9.6% | ||
| Q2 24 | 9.9% | 8.3% | ||
| Q1 24 | 9.9% | 5.9% |
| Q4 25 | $-12.98 | $0.33 | ||
| Q3 25 | $0.40 | $0.46 | ||
| Q2 25 | $0.33 | $0.35 | ||
| Q1 25 | $0.09 | $0.41 | ||
| Q4 24 | $0.36 | $0.67 | ||
| Q3 24 | $0.74 | $0.51 | ||
| Q2 24 | $0.85 | $0.45 | ||
| Q1 24 | $0.83 | $0.30 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $133.2M | $360.4M |
| Total DebtLower is stronger | $2.5B | $3.7B |
| Stockholders' EquityBook value | $1.9B | $4.0B |
| Total Assets | $5.5B | $8.4B |
| Debt / EquityLower = less leverage | 1.28× | 0.94× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $133.2M | $360.4M | ||
| Q3 25 | $118.7M | $399.8M | ||
| Q2 25 | $131.4M | $376.8M | ||
| Q1 25 | $91.2M | $340.9M | ||
| Q4 24 | $76.3M | $329.2M | ||
| Q3 24 | $82.1M | $432.1M | ||
| Q2 24 | $77.2M | $320.0M | ||
| Q1 24 | $77.3M | $340.7M |
| Q4 25 | $2.5B | $3.7B | ||
| Q3 25 | $2.3B | $3.8B | ||
| Q2 25 | $2.3B | $4.0B | ||
| Q1 25 | $2.2B | $4.0B | ||
| Q4 24 | $2.0B | $4.0B | ||
| Q3 24 | $1.9B | $4.1B | ||
| Q2 24 | $1.8B | $4.1B | ||
| Q1 24 | $1.9B | $4.2B |
| Q4 25 | $1.9B | $4.0B | ||
| Q3 25 | $3.1B | $3.9B | ||
| Q2 25 | $3.1B | $3.8B | ||
| Q1 25 | $3.0B | $3.7B | ||
| Q4 24 | $3.1B | $3.7B | ||
| Q3 24 | $3.0B | $3.6B | ||
| Q2 24 | $3.0B | $3.5B | ||
| Q1 24 | $2.9B | $3.4B |
| Q4 25 | $5.5B | $8.4B | ||
| Q3 25 | $6.4B | $8.4B | ||
| Q2 25 | $6.3B | $8.4B | ||
| Q1 25 | $6.1B | $8.4B | ||
| Q4 24 | $6.0B | $8.4B | ||
| Q3 24 | $5.9B | $8.5B | ||
| Q2 24 | $5.7B | $8.3B | ||
| Q1 24 | $5.5B | $8.4B |
| Q4 25 | 1.28× | 0.94× | ||
| Q3 25 | 0.74× | 0.99× | ||
| Q2 25 | 0.74× | 1.05× | ||
| Q1 25 | 0.72× | 1.06× | ||
| Q4 24 | 0.64× | 1.08× | ||
| Q3 24 | 0.62× | 1.15× | ||
| Q2 24 | 0.62× | 1.18× | ||
| Q1 24 | 0.65× | 1.22× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-86.3M | $192.0M |
| Free Cash FlowOCF − Capex | $-179.5M | $134.0M |
| FCF MarginFCF / Revenue | -21.8% | 16.3% |
| Capex IntensityCapex / Revenue | 11.3% | 7.0% |
| Cash ConversionOCF / Net Profit | — | 3.89× |
| TTM Free Cash FlowTrailing 4 quarters | $-439.9M | $396.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-86.3M | $192.0M | ||
| Q3 25 | $73.2M | $249.5M | ||
| Q2 25 | $133.5M | $113.5M | ||
| Q1 25 | $11.5M | $140.4M | ||
| Q4 24 | $116.7M | $176.1M | ||
| Q3 24 | $163.1M | $197.2M | ||
| Q2 24 | $171.1M | $111.2M | ||
| Q1 24 | $-321.3M | $147.2M |
| Q4 25 | $-179.5M | $134.0M | ||
| Q3 25 | $-63.0M | $182.8M | ||
| Q2 25 | $-34.2M | $47.0M | ||
| Q1 25 | $-163.2M | $32.4M | ||
| Q4 24 | $-86.8M | $68.6M | ||
| Q3 24 | $-27.1M | $115.0M | ||
| Q2 24 | $16.9M | $51.9M | ||
| Q1 24 | $-463.7M | $80.6M |
| Q4 25 | -21.8% | 16.3% | ||
| Q3 25 | -7.4% | 22.6% | ||
| Q2 25 | -3.9% | 5.9% | ||
| Q1 25 | -21.2% | 4.2% | ||
| Q4 24 | -11.2% | 8.1% | ||
| Q3 24 | -3.3% | 14.2% | ||
| Q2 24 | 2.1% | 6.4% | ||
| Q1 24 | -60.4% | 10.4% |
| Q4 25 | 11.3% | 7.0% | ||
| Q3 25 | 16.0% | 8.3% | ||
| Q2 25 | 19.3% | 8.4% | ||
| Q1 25 | 22.7% | 14.0% | ||
| Q4 24 | 26.3% | 12.7% | ||
| Q3 24 | 23.3% | 10.2% | ||
| Q2 24 | 19.4% | 7.3% | ||
| Q1 24 | 18.5% | 8.6% |
| Q4 25 | — | 3.89× | ||
| Q3 25 | 2.02× | 3.54× | ||
| Q2 25 | 4.43× | 2.15× | ||
| Q1 25 | 1.37× | 2.23× | ||
| Q4 24 | 3.58× | 1.72× | ||
| Q3 24 | 2.39× | 2.54× | ||
| Q2 24 | 2.18× | 1.64× | ||
| Q1 24 | -4.21× | 3.25× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $451.2M | 55% |
| Comprehensive Treatment Centers | $144.2M | 18% |
| Medicare | $113.7M | 14% |
| Residential Treatment Centers | $89.7M | 11% |
| Self Payor | $16.1M | 2% |
| Other Payor | $10.7M | 1% |
ENTG
| Fabs | $516.3M | 63% |
| Equipment And Engineering | $121.8M | 15% |
| Chemical And Materials | $83.8M | 10% |
| Other | $61.7M | 7% |
| Non Semi | $40.3M | 5% |
